CDT

5.50% -0.0069

アフターアワーズ： .12 0.0015 +1.27%

Conduit Pharmaceuticals Inc (CDT)

Relative Volume:

ネットキャッシュフロー:

Conduit Pharmaceuticals Inc Stock (CDT) Company Profile

Conduit Pharmaceuticals Inc

(760) 471 8536

4995 MURPHY CANYON ROAD, SUITE 300, SAN DIEGO

CDT's Discussions on Twitter

Conduit Pharmaceuticals Inc (CDT) 最新ニュース

Conduit Pharmaceuticals Inc (CDT) 財務データ

Conduit Pharmaceuticals Inc (CDT)

Conduit Pharmaceuticals Inc Stock (CDT) Company Profile

Conduit Pharmaceuticals Inc (CDT) 最新ニュース

In the Green: Conduit Pharmaceuticals Inc (CDT) Closes at 0.13, Up/Down -2.64 from Previous Day - The Dwinnex

CDT Stock Sees Decline of Approximately -3.66% in Last Five Days - Knox Daily

Conduit Pharmaceuticals Inc (CDT) expanding its growth trajectory ahead - SETE News

Conduit Pharmaceuticals Inc [CDT] Insider Activity: An Update for Investors - Knox Daily

Metric Analysis: Conduit Pharmaceuticals Inc (CDT)’s Key Ratios in the Limelight - The Dwinnex

Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Director Andrew Regan Sells 1,514,100 Shares - Defense World

Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Director Andrew Regan Sells 150,000 Shares of Stock - Defense World

CDT Shares Experience Decline in Value - Knox Daily

Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Director Andrew Regan Sells 35,923 Shares - Defense World

Mercer Global Advisors Inc. ADV Reduces Stock Position in Dimensional Emerging Markets Core Equity 2 ETF (NYSEARCA:DFEM) - Defense World

Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Director Andrew Regan Sells 1,005,200 Shares - Defense World

Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Director Andrew Regan Sells 1,389,820 Shares - Defense World

Conduit Pharmaceuticals executive sells over $4.5 million in stock By Investing.com - Investing.com Canada

Conduit Pharmaceuticals executive sells over $4.5 million in stock - Investing.com

Conduit Pharmaceuticals executive sells over $4.5 million in stock By Investing.com - Investing.com UK

Are Smart Investors Making the Right Decision? Conduit Pharmaceuticals Inc (CDT) - SETE News

Akoustis Technologies Inc: How Does AKTS Perform? - Stocks Register

CDT’s Stock Market Adventure: -96.92% YTD Growth Amidst Volatility - The InvestChronicle

Was Conduit Pharmaceuticals Inc (CDT)’s session last reading good? - US Post News

Insider’s View: Deciphering Conduit Pharmaceuticals Inc (CDT)’s Financial Health Through Ratios - The Dwinnex

Conduit Pharmaceuticals Inc [CDT] Revenue clocked in at $0.00 million, down -96.87% YTD: What’s Next? - The DBT News

Conduit Pharmaceuticals Inc (CDT) Stock: A Year of Highs and Lows - The InvestChronicle

Stocks of Conduit Pharmaceuticals Inc (CDT) are poised to climb above their peers - SETE News

Is Conduit Pharmaceuticals Inc (CDT) worth investing in despite its undervalued state? - US Post News

Conduit Pharmaceuticals Inc (CDT)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex

Conduit Pharmaceuticals reschedules annual meeting to December - Investing.com

Conduit Pharmaceuticals reschedules annual meeting to December By Investing.com - Investing.com UK

Healthy Upside Potential: Conduit Pharmaceuticals Inc (CDT) - SETE News

Post-Trade Analysis: Conduit Pharmaceuticals Inc (CDT) Slides -5.38, Closing at 0.12 - The Dwinnex

CDT’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle

Why Zhibao Technology Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket - Benzinga

Market news - Research the market

Vela Technologies reports big drop in asset value - ShareCast

Vela Technologies Reports Mixed Quarterly Results - TipRanks

Short Interest in Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Rises By 386.4% - Defense World

CDT’s Stock Dilemma: Conduit Pharmaceuticals Inc’s Market Performance and Outlook - The InvestChronicle

Conduit Pharmaceuticals Inc (CDT) is looking forward to a strong quarter - SETE News

Conduit Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan

Conduit Pharmaceuticals Inc’s Market Journey: Closing Weak at 0.16, Down -1.64 - The Dwinnex

Conduit Pharmaceuticals Inc (CDT)’s stock chart: A technical perspective - US Post News

AI, Biotech Companies at Risk in Nasdaq's Penny Stock Crackdown - Bloomberg Law

Taking on analysts’ expectations and winning: Conduit Pharmaceuticals Inc (CDT) - SETE News

CDT Stock Earnings: Conduit Pharmaceuticals Reported Results for Q2 2024 - MSN

Conduit Pharmaceuticals Inc Inc. (CDT) Price Performance: A Fundamental Analysis Perspective - The InvestChronicle

Ratio Review: Analyzing Conduit Pharmaceuticals Inc (CDT)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Conduit Pharmaceuticals Inc (CDT) is an excellent investment, but the stock is overvalued/undervalued right now - US Post News

Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) Short Interest Down 11.4% in July - Defense World

CrossFirst Bankshares, Inc. (NASDAQ:CFB) Short Interest Update - Defense World

Conduit Pharmaceuticals faces Nasdaq delisting over market value - Investing.com India

Conduit Pharmaceuticals faces Nasdaq delisting over market value - Investing.com

Conduit Pharmaceuticals faces Nasdaq delisting over market value By Investing.com - Investing.com UK

Conduit Pharmaceuticals Inc (CDT) 財務データ

収益

当期純利益

現金流量

EPS

CDTに似た銘柄